February 25, 2013 Weaker Antibiotic Regulation: Another Problem with FDA's Voluntary Cooperation Program Margaret Mellon Former contributor
February 1, 2013 Negotiating with Drug Companies: The Horse-Trading Behind the FDA's Voluntary Program Margaret Mellon Former contributor
